(AR) Antero Resources - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US03674X1063
Stock: Natural Gas, Oil, Liquids
Total Rating 32
Risk 30
Buy Signal 0.11
| Risk 5d forecast | |
|---|---|
| Volatility | 40.1% |
| Relative Tail Risk | -4.23% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.45 |
| Alpha | -8.86 |
| Character TTM | |
|---|---|
| Beta | 0.914 |
| Beta Downside | 1.885 |
| Drawdowns 3y | |
|---|---|
| Max DD | 33.19% |
| CAGR/Max DD | 0.56 |
EPS (Earnings per Share)
Revenue
Description: AR Antero Resources March 05, 2026
Antero Resources Corporation (AR) is a US-based independent oil and natural gas company. It focuses on developing, producing, exploring, and acquiring natural gas, natural gas liquids (NGLs), and oil properties.
The company operates through three segments: Exploration and Production, Marketing, and an Equity Method Investment in Antero Midstream. This structure is common in the energy sector, allowing companies to manage different stages of the value chain from extraction to sales and infrastructure.
As of December 31, 2025, Antero Resources held significant acreage in the Appalachian Basin (537,000 net acres) and the Upper Devonian Shale (168,000 net acres). These regions are key shale gas plays in the United States. The company also owns 731 miles of gas gathering pipelines in the Appalachian Basin, indicating an integrated approach to its operations.
For more detailed financial and operational insights, consider exploring its profile on ValueRay.
Headlines to watch out for
- Natural gas price fluctuations impact revenue
- NGL and oil prices drive profitability
- Regulatory changes affect drilling permits
- Production costs influence margins
- Midstream investment performance impacts earnings
Piotroski VR‑10 (Strict, 0-10) 7.0
| Net Income: 634.4m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.10 > 0.02 and ΔFCF/TA 3.23 > 1.0 |
| NWC/Revenue: -12.90% < 20% (prev -22.78%; Δ 9.88% < -1%) |
| CFO/TA 0.11 > 3% & CFO 1.63b > Net Income 634.4m |
| Net Debt (4.93b) to EBITDA (1.75b): 2.82 < 3 |
| Current Ratio: 0.55 > 1.5 & < 3 |
| Outstanding Shares: last quarter (312.4m) vs 12m ago -0.34% < -2% |
| Gross Margin: 23.05% > 18% (prev 0.07%; Δ 2298 % > 0.5%) |
| Asset Turnover: 38.12% > 50% (prev 31.66%; Δ 6.47% > 0%) |
| Interest Coverage Ratio: 11.92 > 6 (EBITDA TTM 1.75b / Interest Expense TTM 83.7m) |
Altman Z'' 0.84
| A: -0.05 (Total Current Assets 831.8m - Total Current Liabilities 1.50b) / Total Assets 14.29b |
| B: 0.12 (Retained Earnings 1.68b / Total Assets 14.29b) |
| C: 0.07 (EBIT TTM 997.1m / Avg Total Assets 13.65b) |
| D: 0.26 (Book Value of Equity 1.69b / Total Liabilities 6.57b) |
| Altman-Z'' Score: 0.84 = B |
Beneish M 0.04
| DSRI: 0.82 (Receivables 507.2m/488.0m, Revenue 5.20b/4.12b) |
| GMI: 0.31 (GM 23.05% / 7.09%) |
| AQI: 7.27 (AQ_t 0.15 / AQ_t-1 0.02) |
| SGI: 1.26 (Revenue 5.20b / 4.12b) |
| TATA: -0.07 (NI 634.4m - CFO 1.63b) / TA 14.29b) |
| Beneish M-Score: 0.04 (Cap -4..+1) = D |
What is the price of AR shares?
As of March 09, 2026, the stock is trading at USD 38.83 with a total of 5,421,314 shares traded.
Over the past week, the price has changed by +4.72%, over one month by +13.41%, over three months by +4.10% and over the past year by +11.93%.
Over the past week, the price has changed by +4.72%, over one month by +13.41%, over three months by +4.10% and over the past year by +11.93%.
Is AR a buy, sell or hold?
Antero Resources has received a consensus analysts rating of 3.95.
Therefore, it is recommended to buy AR.
- StrongBuy: 9
- Buy: 5
- Hold: 7
- Sell: 0
- StrongSell: 1
What are the forecasts/targets for the AR price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 44.3 | 14% |
| Analysts Target Price | 44.3 | 14% |
AR Fundamental Data Overview March 08, 2026
P/E Trailing = 19.1281
P/E Forward = 14.4718
P/S = 2.331
P/B = 1.5441
P/EG = 0.2957
Revenue TTM = 5.20b USD
EBIT TTM = 997.1m USD
EBITDA TTM = 1.75b USD
Long Term Debt = 1.40b USD (from longTermDebt, last quarter)
Short Term Debt = 516.3m USD (from shortTermDebt, last quarter)
Debt = 5.14b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 4.93b USD (from netDebt column, last quarter)
Enterprise Value = 16.91b USD (11.98b + Debt 5.14b - CCE 210.0m)
Interest Coverage Ratio = 11.92 (Ebit TTM 997.1m / Interest Expense TTM 83.7m)
EV/FCF = 12.34x (Enterprise Value 16.91b / FCF TTM 1.37b)
FCF Yield = 8.10% (FCF TTM 1.37b / Enterprise Value 16.91b)
FCF Margin = 26.32% (FCF TTM 1.37b / Revenue TTM 5.20b)
Net Margin = 12.19% (Net Income TTM 634.4m / Revenue TTM 5.20b)
Gross Margin = 23.05% ((Revenue TTM 5.20b - Cost of Revenue TTM 4.00b) / Revenue TTM)
Gross Margin QoQ = 26.11% (prev 13.69%)
Tobins Q-Ratio = 1.18 (Enterprise Value 16.91b / Total Assets 14.29b)
Interest Expense / Debt = 0.43% (Interest Expense 22.1m / Debt 5.14b)
Taxrate = 25.63% (69.9m / 272.9m)
NOPAT = 741.5m (EBIT 997.1m * (1 - 25.63%))
Current Ratio = 0.55 (Total Current Assets 831.8m / Total Current Liabilities 1.50b)
Debt / Equity = 0.68 (Debt 5.14b / totalStockholderEquity, last quarter 7.55b)
Debt / EBITDA = 2.82 (Net Debt 4.93b / EBITDA 1.75b)
Debt / FCF = 3.60 (Net Debt 4.93b / FCF TTM 1.37b)
Total Stockholder Equity = 7.36b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.65% (Net Income 634.4m / Total Assets 14.29b)
RoE = 8.63% (Net Income TTM 634.4m / Total Stockholder Equity 7.36b)
RoCE = 11.39% (EBIT 997.1m / Capital Employed (Equity 7.36b + L.T.Debt 1.40b))
RoIC = 8.59% (NOPAT 741.5m / Invested Capital 8.63b)
WACC = 6.59% (E(11.98b)/V(17.12b) * Re(9.28%) + D(5.14b)/V(17.12b) * Rd(0.43%) * (1-Tc(0.26)))
Discount Rate = 9.28% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 0.06%
[DCF] Terminal Value 84.55% ; FCFF base≈1.15b ; Y1≈1.27b ; Y5≈1.62b
[DCF] Fair Price = 109.5 (EV 38.71b - Net Debt 4.93b = Equity 33.78b / Shares 308.5m; r=6.59% [WACC]; 5y FCF grow 11.23% → 2.90% )
EPS Correlation: -49.68 | EPS CAGR: -23.21% | SUE: -0.55 | # QB: 0
Revenue Correlation: -49.69 | Revenue CAGR: -4.76% | SUE: 0.38 | # QB: 0
EPS next Quarter (2026-06-30): EPS=0.61 | Chg7d=+0.012 | Chg30d=-0.027 | Revisions Net=+1 | Analysts=15
EPS current Year (2026-12-31): EPS=3.27 | Chg7d=+0.008 | Chg30d=-0.064 | Revisions Net=-2 | Growth EPS=+90.0% | Growth Revenue=+18.4%
EPS next Year (2027-12-31): EPS=3.91 | Chg7d=-0.004 | Chg30d=-0.220 | Revisions Net=+1 | Growth EPS=+19.5% | Growth Revenue=+5.5%
[Analyst] Revisions Ratio: +0.09 (6 Up / 5 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 4.1% (Discount Rate 9.3% - Earnings Yield 5.2%)
[Growth] Growth Spread = +11.7% (Analyst 15.8% - Implied 4.1%)
P/E Forward = 14.4718
P/S = 2.331
P/B = 1.5441
P/EG = 0.2957
Revenue TTM = 5.20b USD
EBIT TTM = 997.1m USD
EBITDA TTM = 1.75b USD
Long Term Debt = 1.40b USD (from longTermDebt, last quarter)
Short Term Debt = 516.3m USD (from shortTermDebt, last quarter)
Debt = 5.14b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 4.93b USD (from netDebt column, last quarter)
Enterprise Value = 16.91b USD (11.98b + Debt 5.14b - CCE 210.0m)
Interest Coverage Ratio = 11.92 (Ebit TTM 997.1m / Interest Expense TTM 83.7m)
EV/FCF = 12.34x (Enterprise Value 16.91b / FCF TTM 1.37b)
FCF Yield = 8.10% (FCF TTM 1.37b / Enterprise Value 16.91b)
FCF Margin = 26.32% (FCF TTM 1.37b / Revenue TTM 5.20b)
Net Margin = 12.19% (Net Income TTM 634.4m / Revenue TTM 5.20b)
Gross Margin = 23.05% ((Revenue TTM 5.20b - Cost of Revenue TTM 4.00b) / Revenue TTM)
Gross Margin QoQ = 26.11% (prev 13.69%)
Tobins Q-Ratio = 1.18 (Enterprise Value 16.91b / Total Assets 14.29b)
Interest Expense / Debt = 0.43% (Interest Expense 22.1m / Debt 5.14b)
Taxrate = 25.63% (69.9m / 272.9m)
NOPAT = 741.5m (EBIT 997.1m * (1 - 25.63%))
Current Ratio = 0.55 (Total Current Assets 831.8m / Total Current Liabilities 1.50b)
Debt / Equity = 0.68 (Debt 5.14b / totalStockholderEquity, last quarter 7.55b)
Debt / EBITDA = 2.82 (Net Debt 4.93b / EBITDA 1.75b)
Debt / FCF = 3.60 (Net Debt 4.93b / FCF TTM 1.37b)
Total Stockholder Equity = 7.36b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.65% (Net Income 634.4m / Total Assets 14.29b)
RoE = 8.63% (Net Income TTM 634.4m / Total Stockholder Equity 7.36b)
RoCE = 11.39% (EBIT 997.1m / Capital Employed (Equity 7.36b + L.T.Debt 1.40b))
RoIC = 8.59% (NOPAT 741.5m / Invested Capital 8.63b)
WACC = 6.59% (E(11.98b)/V(17.12b) * Re(9.28%) + D(5.14b)/V(17.12b) * Rd(0.43%) * (1-Tc(0.26)))
Discount Rate = 9.28% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 0.06%
[DCF] Terminal Value 84.55% ; FCFF base≈1.15b ; Y1≈1.27b ; Y5≈1.62b
[DCF] Fair Price = 109.5 (EV 38.71b - Net Debt 4.93b = Equity 33.78b / Shares 308.5m; r=6.59% [WACC]; 5y FCF grow 11.23% → 2.90% )
EPS Correlation: -49.68 | EPS CAGR: -23.21% | SUE: -0.55 | # QB: 0
Revenue Correlation: -49.69 | Revenue CAGR: -4.76% | SUE: 0.38 | # QB: 0
EPS next Quarter (2026-06-30): EPS=0.61 | Chg7d=+0.012 | Chg30d=-0.027 | Revisions Net=+1 | Analysts=15
EPS current Year (2026-12-31): EPS=3.27 | Chg7d=+0.008 | Chg30d=-0.064 | Revisions Net=-2 | Growth EPS=+90.0% | Growth Revenue=+18.4%
EPS next Year (2027-12-31): EPS=3.91 | Chg7d=-0.004 | Chg30d=-0.220 | Revisions Net=+1 | Growth EPS=+19.5% | Growth Revenue=+5.5%
[Analyst] Revisions Ratio: +0.09 (6 Up / 5 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 4.1% (Discount Rate 9.3% - Earnings Yield 5.2%)
[Growth] Growth Spread = +11.7% (Analyst 15.8% - Implied 4.1%)